Results 71 to 80 of about 2,317 (166)

Comparative analysis of the efficiency of the selective b-blocker nebivolol and the angiotensin II receptor blocker valsartan in men with hypertension, metabolic syndrome, and erectile dysfunction

КардиоСоматика, 2013
Objective: to evaluate the antihypertensive efficacy and effect of nebivolol and valsartan on metabolic parameters and erective function in patients with hypertension, metabolic syndrome, and erectile dysfunction. Subjects and methods.
S. V Nedogoda, A. S Salasyuk, I. N Barykina, A. A Ledyaeva, V. V Tsoma, E. V Chumachek   +5 more
doaj  

Nebivolol effect on oxidative biomarkers in Tamoxifen-Induced Hepatotoxicity in Female White Albino Rats: In Vivo Study

Al-Mustansiriyah Journal of Pharmaceutical Sciences
Liver injury can arise post-exposure to drugs or their metabolites, as well as herbal and dietary supplements. Tamoxifen is a frequently used drug in breast cancer treatment.
Noor Ahmed Hammadi, Yassir Mustafa Kamal almullahummadi, Huda Jaber Waheed   +2 more
doaj   +1 more source

Pulmonary effects of nebivolol

Therapeutic Advances in Cardiovascular Disease, 2009
The pharmacological control of arterial hypertension is a very frequent issue in clinical practice and some critical aspects can arise in particular circumstances and with particular molecules. In the case of hypertensive subjects with respiratory comorbidities, when first introduced, these β-adrenergic receptor antagonists were described as affecting
openaire   +2 more sources

Nebivolol therapy and reduction of intravascular platelet activity in patients with atrial hypertension and metabolic syndrome

Кардиоваскулярная терапия и профилактика, 2006
Aim. To assess nebivolol clinical effects on intravascular platelet activity in patients with arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 21 patients were administered nebivolol (5 mg/d) for one month. Dynamics
I. N. Medvedev
doaj  

Use of nebivolol in patients with mild and moderate hypertensive disease

Терапевтический архив, 2003
Aim. To evaluate the effectiveness and safety of the beta-adrenoblocker nebivolol in patients with mild and moderate essential hypertension. Material and methods. The trial enrolled 20 patients.
L V Zhigunova, Ye L Lakhova, A P Yurenev
doaj  

Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction

Bangladesh Journal of Pharmacology, 2013
We aimed to investigate the pharmacoeconomic efficacy of ivabradine and nebivolol in treatment of stable angina pectoris patients with left ventricular dysfunction prospectively. Pharmacoeconomic analysis was performed by using cost minimization analysis,
Rasim Kutlu, Mehmet Erdem Memetoglu, Tolkun Murataliev Muratalievic   +2 more
doaj  

A Comparative Study of Nebivolol and Metoprolol on Blood Pressure and Heart Rate in Essential Hypertensive Patients

, 2015
Komaram Ravibabu, K. Radha Ramana Murthy, N Lakshmana Rao, P Jayasree, Tsn Akhila   +4 more
openalex   +1 more source

ENHANCED ORAL BIOAVAILABILITY OF NEBIVOLOL HYDROCHLORIDE THROUGH LIQUISOLID APPROACH: APPLICATION OF NOVEL EXCIPIENTS

, 2017
Shaym Sunder R Narender Naik G
openalex   +1 more source

Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure [PDF]

, 2017
Brian L. Stauffer, Caitlin A. Dow, Kyle J. Diehl, Tyler D. Bammert, Jared J. Greiner, Christopher A. DeSouza   +5 more
openalex   +1 more source

Nebivolol [PDF]

, 2020
openaire   +1 more source